How is Sweet Syndrome diagnosed?

Sweet Syndrome, also known as acute febrile neutrophilic dermatosis, is primarily diagnosed through a combination of clinical physical examination and a skin biopsy confirming dense neutrophilic infiltration. While blood tests often show elevated inflammatory markers, the diagnosis relies heavily on meeting established clinical criteria, as there is no single "gold standard" blood test for the condition.

How is Sweet Syndrome diagnosed?

The diagnostic process for Sweet Syndrome typically begins with a physical exam of the characteristic painful, red, raised skin lesions. Because the condition is rare, patients often experience a "diagnostic odyssey," waiting weeks or months for an accurate diagnosis. Physicians utilize the Von den Desser and Goerz criteria to confirm Sweet Syndrome, which require the presence of both major criteria and at least two minor criteria.

What are the key diagnostic tests?

To confirm a Sweet Syndrome diagnosis, clinicians generally perform the following:

• Skin Biopsy: The most critical test, showing a dense infiltrate of mature neutrophils in the upper dermis without evidence of vasculitis.


• Complete Blood Count (CBC): Frequently reveals neutrophilic leukocytosis (elevated white blood cells).


• Inflammatory Markers: Elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are almost universal.


• Imaging: Chest X-rays or CT scans may be ordered to screen for underlying malignancies, as Sweet Syndrome is occasionally paraneoplastic.

Which specialists are involved in the diagnosis?

Diagnosis is usually spearheaded by a dermatologist or a rheumatologist. Because Sweet Syndrome can mimic infections or cellulitis, it is frequently misdiagnosed initially. If you feel your current team is unfamiliar with the condition, seeking a referral to an academic medical center or a specialist in autoinflammatory diseases is essential to ending the diagnostic delay.

What conditions are confused with Sweet Syndrome?

The differential diagnosis for Sweet Syndrome is broad. It is often mistaken for severe cellulitis (a bacterial infection), erythema nodosum, or drug-induced eruptions. Unlike infections, Sweet Syndrome often fails to respond to antibiotics, which is a clinical clue that often prompts physicians to reconsider the diagnosis.

Next steps

• Consult a board-certified dermatologist or rheumatologist experienced in rare inflammatory skin conditions.


• Connect with the 73 members of the Sweet Syndrome community at DiseaseMaps.org to share experiences and provider recommendations.


• Request a copy of your pathology report to ensure the biopsy was reviewed by a dermatopathologist.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sweet Syndrome overview.


• Orphanet: Rare disease portal for Acute Febrile Neutrophilic Dermatosis.


• PubMed/NCBI: Diagnostic criteria for Sweet Syndrome (Von den Desser and Goerz).